News
5h
TipRanks on MSNAstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...
Here is our list of the 11 best cancer stocks to buy right now.
In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...
The cause of death of the beloved 'WKRP in Cincinnati' actress, who died on Aug. 3, has finally been confirmed.
Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...
Actress Loni Anderson's cause of death revealed to be metastatic uterine leiomyosarcoma, according to a death certificate obtained by TMZ.
An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...
2d
TipRanks on MSNBioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer
The intervention being tested is BNT323/DB-1303, an investigational drug administered via intravenous infusion. It is compared against standard chemotherapy options, doxorubicin or paclitaxel, chosen ...
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...
The National Cancer Institute of the National Institutes of Health has awarded Dr. Anna Gottschlich, assistant professor of oncology in the Wayne State University School of Medicine and the Barbara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results